Shumaila, et al. “Long-Term Safety and Efficacy of Janus Kinase (JAK) Inhibitors in the Treatment of Rheumatoid Arthritis: Disease Control in Rheumatoid Arthritis With JAK Inhibitors”. DEVELOPMENTAL MEDICO-LIFE-SCIENCES, vol. 1, no. 4, Sept. 2024, pp. 71-78, https://doi.org/10.69750/dmls.01.04.039.